METASTATIC PANCREATIC CANCER
Clinical trials for METASTATIC PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail targets Hard-to-Treat liver cancers
Disease control TerminatedThis study tested a combination of three drugs—nivolumab, tadalafil, and vancomycin—in adults with liver cancer or liver tumors that spread from colorectal or pancreatic cancer when standard treatments failed. The goal was to see if the drugs could shrink tumors. The study was st…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:43 UTC
-
New pancreatic cancer combo trial halted early
Disease control TerminatedThis early-phase trial tested whether adding the experimental drug YL-13027 to standard chemotherapy (gemcitabine and nab-paclitaxel) is safe for people with advanced pancreatic cancer that had stopped responding to previous treatment. Only 4 participants were enrolled before the…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Pancreatic cancer drug combo study ends early
Disease control TerminatedThis study tested a new drug called NIS793 combined with standard chemotherapy (FOLFIRINOX) for people with advanced pancreatic cancer that had spread. The goal was to see if the combination was safe and could help shrink tumors enough for surgery. Only 4 people took part before …
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE1 • Sponsor: Colin D. Weekes, M.D., PhD • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Promising drug trial for pancreatic cancer halted early
Disease control TerminatedThis study tested a drug called niraparib as a first treatment for people with metastatic pancreatic cancer that has certain gene changes (HR-deficient). Only 2 people enrolled before the trial was stopped early. The goal was to see if the drug could shrink tumors, but results ar…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated May 18, 2026 12:00 UTC
-
Weight-Loss drug trial for pancreatic cancer stalls
Symptom relief TerminatedThis study tested a drug called anamorelin to see if it could help prevent weight loss and improve appetite in people with advanced pancreatic cancer who were starting chemotherapy. The trial planned to enroll about 100 participants but was stopped early with only 4 people taking…
Matched conditions: METASTATIC PANCREATIC CANCER
Phase: PHASE2 • Sponsor: Lahey Clinic • Aim: Symptom relief
Last updated May 26, 2026 09:46 UTC